$GBTG

Williams Karen A sold $94K of GBTG

Williams Karen A (Chief Financial Officer) sold 10,000 shares of Global Business Travel Group, Inc. (GBTG) at $9.35 on 2026-06-08.

Original reporting
SEC EDGAR · Williams Karen A
Published Jun 10, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 10, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GBTG
Bearish
medium confidence
Mentioned
$GBTG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GBTGBearishLow
01

Why it matters

The newest fact is the CFO’s open-market sale of 10,000 shares at $9.35, which may modestly affect sentiment but does not provide operational or financial updates.

02

Market read

Traders may monitor for follow-on insider activity, but there is no direct fundamental catalyst in the text.

03

What to watch

Check whether other insiders also sold/bought around the same window and whether the company has upcoming catalysts (earnings, guidance, financing) not mentioned here.

Relevance 3/10Novelty 6/10Timing: filed 2026-06-10 (sale dated 2026-06-08)

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Global Business Travel Group, Inc.

Company-level read

Ticker impact

$GBTGBearishMedium confidence
Context

CFO Karen A. Williams filed an open-market sale of 10,000 shares at $9.35 on 2026-06-08 via SEC Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing discloses a specific sale size and price, but insider sales alone rarely drive sustained repricing without accompanying company news.

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or personal liquidity needs; absence of a 10b5-1 plan doesn’t necessarily imply bearish fundamentals.

Key entities

  • Global Business Travel Group, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Karen A. Williams

    CFO who sold 10,000 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HRLMedAI 8/10

Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankrupt

Hormel (HRL) acquires Brakebush for $1.06B; Onsemi (ON) to buy Synaptics for $5.7B; Leslie's files for bankruptcy. Valley National (VLY) to acquire Bluevine for $340M. Yext (YEXT) to acquire Flamel.ai. Lifecore (LFCR) to be acquired by Webster Equity for up to $663.7M. SoftBank completes DigitalBridge acquisition. GBTG acquired by Long Lake for $6.3B.

$INTUMed

Q2 Earnings Highs And Lows: Intuit (NASDAQ:INTU) Vs The Rest Of The Finance and HR Software Stocks

Intuit (INTU) reported Q2 revenue of $4.35B, up 13.7% YoY, but missed EPS guidance, causing shares to drop 12.5%. American Express Global Business Travel (GBTG) saw 37.9% revenue growth, beating estimates. Marqeta (MQ) reported $176M revenue, up 17% YoY, but missed guidance. Paylocity (PCTY) beat estimates with 11% growth. BlackLine (BL) reported $187.8M revenue, in line with expectations but down 13.2% post-earnings.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).